CHESTER, N.Y., June 5 /PRNewswire-FirstCall/ -- Repro-Med Systems, Inc. (OTC:REPR.OB) (BULLETIN BOARD: REPR.OB) , the leading developer and manufacturer of portable medical devices for infusion therapy and respiratory products, today announced a Freedom60(R) supply agreement with Chartwell Pennsylvania, L.P., a provider of home infusion and enteral nutrition therapy services along with clinical monitoring, dietary consultation, infusion nursing, pump management and delivery services. "We understand how important it is for Chartwell to maximize the quality of life and dignity of the patients and clients they serve. We're pleased that Chartwell has the confidence that the Freedom60(R) will enhance their clients' experience and are confident that Chartwell and their patients will enjoy the precision and independence provided by the Freedom60(R)," said Andy Sealfon, President of Repro-Med. "Chartwell is committed to providing high quality infusion therapy services, ensuring safe, quality, and cost-effective infusion therapy at home. We believe that Repro-Med's Freedom60(R) will contribute to our provision of the highest level of patient treatment outcomes in a low-cost, patient-preferred home setting," stated Lynn Giglione RN BSN, Chartwell's General Manager. About Chartwell Chartwell provides a complete constellation of clinical, administrative, and care coordination services provided by home infusion pharmacy organizations. Chartwell is committed to caring for patients with a wide range of diagnoses and home infusion therapy needs, providing a clinically safe and effective alternative to hospitalization. Chartwell employs more than 100 highly skilled clinical and supportive professionals including nurses, pharmacists, reimbursement experts and customer service specialists who are committed to providing the highest level of service possible to patients. Working in partnership with local physicians, hospitals and nursing agencies, the clinical staff is dedicated to making sure each patient experiences a positive, successful therapy outcome in the comfort of their own home. About Repro-Med Repro-Med Systems, Inc. engages in the design and manufacture of hand powered portable medical devices for emergency respiratory applications and infusion therapy worldwide. Repro-Med manufactures medical devices for a variety of markets including hospital, emergency-care and home-care. The Company's primary products are Freedom60(R) and Res-Q-Vac(TM). The Freedom60(R) Syringe Infusion Pump provides a portable, high quality, self powered, maintenance free delivery system for home, ambulatory and hospital use. The patented mechanical variable rate flow control device delivers precise infusion rates and uniform flow profiles that provide consistent transfer of medication. The Freedom60(R) is a versatile, easy-to-use lightweight mechanical pump providing a cost-effective alternative to expensive electronic and disposable IV administration devices used to deliver a wide range of infusion products including antibiotics, pain control, chemotherapy drugs, immune globulin, desferal and cardiac drugs. Res-Q-Vac(TM) is currently the market leader in providing a portable hand powered suction system designed to remove fluids from a patient's airway. The Res-Q-Vac(TM) patented Full Stop Protection Filter(TM) and disposable design eliminate the risk of contaminating the health care provider when suctioning a patient or during post treatment cleanup. The product is ideally suited for hospitals and emergency providers for primary suction needs or as backup support for powered suction systems. Forward Looking Statements Statements in this press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, may be forward-looking statements. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. These statements involve risks and uncertainties that could cause actual results to differ materially from those included in forward-looking statements due to a variety of factors. More information about these factors can be found in Repro-Med's latest Annual Report filed with Securities and Exchange Commission on Form 10-KSB. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Contact: Repro-Med, Inc. Andrew Sealfon, 800.624.9600 DATASOURCE: Repro-Med Systems, Inc. CONTACT: Andrew Sealfon of Repro-Med, Inc., 1-800-624-9600 Web site: http://www.repro-med.com/

Copyright